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A B S T R A C T
Background: Heart rate (HR) at the ventilatory threshold (VT) is often used to prescribe exercise intensity
in cardiac rehabilitation. Some studies have reported no signiﬁcant difference between HR at VT and HR
measured at the end of a 6-min walk test (6-MWT) in cardiac patients. The aim of this work was to assess
the potential equivalence between those parameters at the individual level.
Method: Three groups of subjects performed a stress test and a 6-MWT: 22 healthy elderlies (GES,
77  3.7 years), 10 stable coronary artery disease (CAD) patients (GMI, 50.9  4.2 years) and 30 patients with
chronic heart failure (GHF, 63.3  10 years). We analyzed the correlation, mean bias, 95% conﬁdence interval
(95% CI) of the mean bias and the magnitude of the bias between 6-MWT-HR and VT-HR.
Results: There was a signiﬁcant difference between 6-MWT and VT-HR in GHF (99.1  8.8 vs
91.6  18.6 bpm, P = 0.016) but not in GES and GMI. The correlation between those 2 parameters was
high for GMI (r = 0.78, P < 0.05), and moderate for GES and GHF (r = 0.48 and 0.55, respectively, P < 0.05). The
95% CI of bias was large (> 30%) in GES and GHF and acceptable in GMI (8–12%).
Conclusion: 6-MWT-HR and VT-HR do not appear interchangeable at the individual level in healthy
elderlies and CHF patients. In CAD patients, further larger studies and/or the development of other walk
tests could help in conﬁrming the interest of a training prescription based on walking performance, after
an exhaustive study of their cardiometabolic requirements.




Exercise training is one of the core components of cardiac
rehabilitation (CR), with secondary prevention program [1,2]. How-
ever, the optimal method to personalize training intensity remains
controversial, as recommendations vary considerably (ranging
from 50 to 100% of the maximal exercise capacity) [1–3].
Cardiopulmonary exercise testing (CPET) is recommended in
entering CR, ﬁrstly in order to screen for potential myocardial
ischemia, for threatening arrhythmia or for effort-induced
hypertension. CPET can also be used to help in estimating the
prognosis of mortality [4], to evaluate the maximal and
submaximal exercise capacity and prescribe tailored program
for physical activity,[5] particularly during CR [6]. Training* Corresponding author.
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1877-0657/ 2014 Elsevier Masson SAS. All rights reserved.intensity is usually prescribed at a target heart rate (THR) [7],
commonly set at the HR corresponding to the ﬁrst ventilatory
threshold (VT) [8–11]. Indeed, one of the main aims of CR is to
improve submaximal aerobic capacity. However, no robust
prospective studies clearly support the systematic use of the
THR at the ﬁrst VT in CAD patients. Moreover, considering the
prevalence of cardiovascular disease, it is difﬁcult to perform a
CPET with VO2measurement for all these patients, as it requires a
specialized infrastructure and expensive resources. In addition, a
CPET could be contraindicated for debilitated patients because it
exposes to musculoskeletal damage and to various cardiac events
[12]. Finally, CPET may be perceived as an unpleasant experience,
thus leading to a lack of motivation to reach maximal effort that
can alter the results signiﬁcance.
Other easier and faster testing modalities thus appear useful to
evaluate patients at various submaximal levels that are more
relevant to daily activities [13,14] Even if there are still no
recommendations regarding potential alternatives to CPET,
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more used. The 6-min walk test (6-MWT) is now widely proposed
to assess functional exercise capacity and prognosis since it is
reproducible, well tolerated and corresponds to submaximal
moderate exercise. Some studies showed that its relative intensity
corresponds approximately to the ﬁrst VT in elderly and cardiac
patients [13,15–18], whereas other authors found that HR or VO2
recorded during the 6-MWT was higher than that observed at this
ﬁrst VT in elderlies [19], and chronic heart failure (CHF) patients
[20,21].
In a recent pilot study, Gremeaux et al. showed that setting
exercise intensity prescription at the HR measured at the end of the
6-MWT allowed to obtain a similar exercise capacity improvement
than with a conventional protocol using a training HR derived from
maximal HR of the CPET [18]. Another study showed that walking
speed at self selected (comfortable) velocity could be used to
personalize training intensity in CAD patients [22], with the
advantage of being perceived as pleasant, which is a positive point
for a really prolonged behavioral change [23].
The aim of this work was to assess the potential equivalence
between the 6-MWT-HR and the ﬁrst VT-HR at the individual level
in 3 populations for whom exercise training is recommended in
primary or secondary prevention: healthy elderly subjects,
coronary artery disease patients, and CHF patients.
2. Methods
2.1. Participants
Participants were included if they had completed an exercise
training program or a CR program. Patients were not included if
they presented: signiﬁcant cognitive disorders that hampered
participation in the tests (Mini Mental State examination  24);
atrial ﬁbrillation; acute or chronic respiratory failure; or any
associated disease that limited walking capacity apart from aging
or cardiac disease. All data were collected on a personal form,
included in the patient’s medical ﬁle. This study was approved by
the local ethic committee, and informed written consent was
obtained for all participants after they had been informed of all of
the risks, the discomfort and beneﬁts involved in this study.
2.1.1. Elderly participants (GES group)
They were healthy community-dwelling older volunteers
enrolled in a large prospective study investigating the effects of
one-year exercise training program in healthy elderlies [24]. Twen-
ty two participants completed this program combining aerobic and
strength training, in line with recommendations [2]. Sessions were
performed in the rehabilitation department of Dijon University
Hospital twice a week and at home once a week [24].
2.1.2. Cardiac (coronary and CHF) patients (GMI and GHF groups)
Patients were included without distinction of gender, if they
were aged between 35 and 80 years; they were at the end of an
outpatient program of CR [1,25]; they had been referred for:
myocardial infarction, coronary angioplasty ( stenting), coronary
artery bypass surgery, stable angina, CHF. CHF was deﬁned as left
ventricular ejection fraction < 45% using the echocardiographic
Simpson method. Patients were excluded if they presented: renal
failure, exercise-induced arrhythmia, or residual myocardial ische-
mia; pacemaker; severe obstructive heart disease; moderate to severe
aortic stenosis; intracavitary thrombosis; pulmonary hyperten-
sion > 70 mmgHg; modiﬁcation of drugs affecting adaptation to
effort within the 15 days preceding the tests (diuretics, angiotensin
conversion enzyme inhibitor, angiotensin receptor antagonist 2, beta-
blockers, anti-aldosterone, ivabradine). On the other hand, the drugs
class, even inﬂuencing the HR (for example beta-blocker), was not anexclusion criterion. Sessions were performed in the rehabilitation




At baseline and after the training period, participants
performed a symptom-limited CPET on a cycle ergometer and a
6-MWT. The walk test was performed 2 to 4 days after the CPET.
We only analyzed the post-training data, in order to avoid the
inﬂuence of potential medical treatment modiﬁcations, especially
in the GMI and GHF groups.
2.2.2. Symptom-limited CPET
Each participant performed one symptom-limited incremental
CPET on a cycloergometer (Lode, Groningen, Netherlands). After a
1-min warm-up period pedaling at 20 W, the work rate was
increased by 10 W every minute. A 12-lead electrocardiogram
(Cardiosystem Marquette Hellige, Milwaukee, Wisconsin, USA)
was continuously monitored. Left arm blood pressure was
measured every 2 min using a standard cuff mercury sphygmo-
manometer. Gas exchange was measured breath-by-breath by a
computerized system (CPX, Medical Graphics, St. Paul, MN). The
exercise was stopped when the subject was unable to maintain the
imposed pedaling rhythm of 60 revolutions per minute, and the
reason for stopping (dyspnea, exhaustion, leg fatigue) was noted.
Before each test, the system was calibrated with a 3-L Rudolph
syringe and a standard gas of known concentration. The inspiratory
airﬂow and the fraction of expired oxygen and carbon dioxide were
measured every second. Averages were then established every ten
seconds for ventilation, oxygen uptake, carbon dioxide production,
respiratory ratio and breathing frequency. Peak VO2 and peak HR
were deﬁned as the mean oxygen uptake and heart rate values
during the last 30 s of exercise. The ﬁrst VT was determined by two
blinded and independent investigators, using Wasserman’s
method [26]. HR value corresponding to the ﬁrst VT was noted.
2.2.3. Walk tests
The 6-MWT walk test was administered by a therapist blinded
to the CPET result. It was performed on a 50-m unobstructed path.
The patients were instructed to walk at a self-selected pace from
one end of the path to the other and back, in order to cover as much
distance as they could during the allotted time. The test was
monitored and the time was called out every 2 min. Standard
encouragement at 30-s intervals was provided. Slowing down and
stopping to rest were permitted. At the end of 6 min, the total
distance walked in meters (m) was measured. These technical
aspects are in line with the American Thoracic Society recom-
mendations for the 6-MWTc (32). At ﬁrst, the patients performed a
familiarization test in order to avoid learning effects.
HR was monitored throughout the walk-test with a telemetric
device (Teleguard, GE Medical Systems, Denmark) and the highest
value was noted during the last 30 s of the test. These values
allowed assessment of relative cardiac intensity of the 6-MWT
with respect to the CPX maximal HR. Blood pressure was measured
before and immediately after each test at the left arm using a
standard cuff mercury sphygmomanometer. Any clinical symp-
toms such as angina were recorded.
2.3. Statistical analysis
Standard statistical methods were used for the calculation of
means and standard deviations.
Normal Gaussian distribution of the data was veriﬁed by the
Shapiro-Wilk test and homoscedasticity by a modiﬁed Levenne
Table 1
Patient’s clinical and anthropometric data.
Elderlies (n = 24) CAD (n = 10) CHF (n = 30)
Age (yrs) 77.2  3.6 50  8.5 61.7  10.7
Sex (M/F) 12/12 10/0 22/8
Height (cm) 162.8  6.3 178  6 170  7.3
Weight (kg) 67.4  11.6 81.7  15 73.2  14.5
BMI (kg/m2) 25.3  3 25.8  4.1 25.2  4.1
Medications (n)
b-bloquers 10 30
ACE inhibitors 10 25
ARB 0 4
Diuretics 0 19
M: male; F: female; BMI: body mass index; CAD: coronary artery disease; CHF:
chronic heart failure; ACE: angiotensin-converting enzyme; ARB: angiotensin
receptor blockers.
Table 2
Maximal exercise test and walk tests results in the 3 groups.
GES (n = 22) GMI (n = 10) GHF (n = 30)
Peak VO2 (mL/min/kg) 21.6  4.2 27.4  6.6 19.6  5.8
VT VO2 (mL/min/kg) 14.4  2.4 19.2  7.8 11.9  4.2
ET peak HR (bpm) 134.8  16.2 126.2  11.6 116.9  24
VT HR (bpm) 104.2  14.3 94.2  4.8 91.6  18.6
VT relative intensity (% maxHR) 77.20% 74.60% 78.30%
6-MWT HR (bpm) 104.04  16.8 92.1  6.8 99.1  18.8
VT relative intensity (% maxHR) 77.20% 73% 84.70%
6-MWT distance (m) 464.9  60.1 559.7  54.8 485.9  92.3
mL: milliliters; min: minute; kg: kilograms; CPET: cardio-pulmonary exercise test;
HR: heart rate; VT: ventilatory threshold; 6-MWT: 6-min walk test.
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repeated measures, was assessed with a non-parametric Wilcoxon
matched pairs test. The magnitude of difference was assessed by
the Hedges’ g (g), calculated as follows [27]: g = J  d; where J is a
correction factor calculated according to Eq. 1 et d is Cohen’ d,
calculated according to Eq. 2.
Eq. 1:
J ¼ 1  3
4d f  1
where df represents the degrees of freedom (df = n–1 in the case
of dependant groups);
Eq. 2:
d ¼ M1  M2
Swithin
where M1 and M2 are the mean of the ﬁrst and the second trials




2 1  rð Þp
where Sdiff is the standard deviation of differences between
pairs and r is the correlation between pairs).
The scale proposed by Cohen was used for interpretation [28]
The magnitude was considered either very small (g < 0.2), or smallTable 3
Heart rate during the 6-min walk test and at the ventilatory threshold during the sympto
for the bias and magnitude of the bias. Data are reported as mean  standard deviation
Population Heart rate (bpm) Correlation
6 WT VT 
GES (n = 22) 104.4  16.8 104.2  14.3 0.48* 
GMI (n = 10) 92.1  6.8 94.2  4.8 0.78* 
GHF (n = 30) 99.1  18.8 91.6  18.6 0.55* 
*P < 0.05; VT: ventilatory threshold; 6-MWT: 6-min walk test; bpm: beat per minute; (0.2 < g  0.5), or moderate (0.5 < g  0.8), or large (g > 0.8).
Spearman rank order correlation was used to assess the association
between heart rate during the 6-MWT and heart rate at the VT
during the CPET. We considered a correlation over 0.90 as very
high, between 0.70 and 0.89 as high and between 0.50 and 0.69 as
moderate [29]. Statistical analysis was performed with Statistical
software (Statsoft, Maison Alfort, France). Differences were
considered signiﬁcant when P < 0.05.
3. Results
3.1. Participants
Table 1 describes the main characteristics of participants
included. Brieﬂy, in the GES, patients were 77.2  3.6 years old;
whereas in the GMI and GHF they were 50  8.5 and 61.7  10.7,
respectively. Mean BMI showed overweight for all 3 groups, and all
CAD and CHF patients were under optimal medical treatment.
3.2. Walk tests and Maximal exercise capacity
Mean peak VO2, VO2 at the ﬁrst VT, peak HR during CPET, and
HR at the ﬁrst VT and at the end of the 6-MWT are summarized in
Table 2.
3.3. Correlation and bias between 6-MWT HR and VT-HR
The correlation, mean bias, 95% conﬁdence interval (95% CI) of
the mean bias and the magnitude of the bias between 6-MWT-HR
and VT-HR are reported in Table 3. We evidenced a moderate
difference between 6-MWT and VT-HR in GHF (99.1  18.8 vs
91.6  18.6 bpm, P = 0.016, ES = 0.44) but not in GES and GMI.
Relative intensity of the 6-MWT and VT, expressed as a percentage of
maximal HR, was thus higher in the GHF only (84.7% vs 78.3%;
P < 0.05). The correlation between those 2 parameters was high for
GMI (r = 0.78, P < 0.05), and moderate for GES and GHF (r = 0.48 and
0.55, respectively, P < 0.05). The 95% CI of bias was large (> 30%) in
GES and GHF and acceptable in GMI (8–12%). The magnitude of the
bias assessed by the Hedges’ g (g) was trivial for GES (0.01  0.29),
and low for GMI and GHF (0.3  0.41 and 0.44  0.22, respectively).
Fig. 1 illustrates Bland and Altman plots for each groups, showing a
heteroscedastic distribution with 3 outliers for GHF, and a home-
oscedastic distribution for GES and GMI, with one outlier in this
latter group.
4. Discussion
Our study showed that, in these groups of elderlies and cardiac
patients who completed a training program, the 6-MWT HR and
the ﬁrst VT-HR were not statistically different in GES and GMI.
However, whether these two potential training targets HR can
replace one other at the individual level remains questionable,
especially in the elderlies (mean bias = 0.2  15.9 and 95%
CI > 30%). Finally, we evidenced a signiﬁcant difference between
those parameters in CHF patients.m-limited cardiopulmonary exercise test: correlation, bias, 95% conﬁdence interval
, by the exception of Hedges g (mean  standard error).
 Bias 95% CI for the bias Hedges g
(bpm) (bpm)
0.2  15.9 33.5 < m1m2< 33.9 0.01  0.29
2.1  4.3 12.3 < m1m2< 8.1 0.3  0.41
7.5  17.8 28.9 < m1m2< 43.9 0.44  0.22
CI: conﬁdence interval.
Fig. 1. Bland et Altman plots for the 3 groups GES (A); GMI (B) and GHF (C).
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ﬁrst VT-HR has never been investigated at the individual level in
those populations.
The potential differences regarding relative intensity of the 6-
MWT in elderlies when compared to the study of Kervio et al.
might be partially explained by the patients’ characteristics
[19]. Indeed, our subjects were older (77.2  3.6 vs 64.7  1.4),
had a lower BMI (25.3  3 vs 26.4  0.7). Moreover, they just
completed a one-year training program that improved their exercise
capacity and might have increased the ﬁrst VT level. Finally, there are
still controversies regarding walking speed instructions during the 6-
MWT, that can, at least partially, explain the difference evidenced in
those studies. Indeed, the 6-MWT has been ﬁrst developed for the
functional evaluation of CHF patients [30], but has been largely
developed and used in chronic respiratory diseases, where it is
supposed to measure ‘‘the distance that a patient can quickly walk’’
[31]. The ATS recommendations thus state that ‘‘the object of this test
is to walk as far as possible for 6 min. You will walk back and forth in
this hallway. Six minutes is a long time to walk, so you will be exerting
yourself. You will probably get out of breath or become exhausted’’.
These recommendations may participate to lead patients to perform
the walk test at an intensity close to that of peak VO2 [32]. However, in
the initial description of the test by Guyatt, CHF patients (NYHA class
3) are not encouraged to achieve an exhausting effort, but rather to
‘‘cover as much ground as they could during the allotted time’’,
without instruction regarding walking speed or effort intensity
[30]. Recommending a self-selected speed (‘‘self-paced’’ or comfort-
able speed) appears fundamental, as it corresponds to the greatest
energetic efﬁciency for a given subject (i.e. the lowest energy
expenditure per meter) [33].
Concerning GHF, we evidenced a signiﬁcant difference between
the 6-MWT HR and the ﬁrst VT-HR, in line with other studies
conducted by Kervio et al. among CHF patients [20,21]. However,
the difference in relative intensity of ﬁrst VT and 6-MWT,
expressed as a percentage of max HR, was less marked in our
study (78.3% vs 84.7%, respectively, and 75% vs 90% in the study by
Kervio et al). This might be explained by the lowest severity of the
disease in ours sample. Indeed, Jehn et al. reported that this could
signiﬁcantly inﬂuence the 6-MWT relative intensity [34]. This has
led certain authors to propose an adjustment of the instructions by
using the Borg scale [35]. Thus, patients are asked to limit their
efforts’ intensity during the 6-MWT at a level placed between
11 and 13 on the 6–20 Borg scale in order to avoid an early
exhaustion and to make sure of a submaximal test. This method
appeared reproducible but was only studied during a treadmill
test. Nevertheless, the idea to use the Borg’s scale is interesting
because the ‘‘Rate of Perceived Exhaustion’’ (RPE) appears to be
correlated with certain physiological parameters. Thus, in the
meta-analysis by Chen et al. among healthy subjects [36], RPE wasfound to be signiﬁcantly correlated with several physiological
parameters usually considered in the determination of the ﬁrst VT
such as VO2 (r = 0.63), ventilation (r = 0.61) and blood lactate levels
(r = 0.57). A more recent review performed by Coquart et al. [37]
concluded that the individual relationship between RPE and VO2
(RPE/VO2) can be used to predict VO2 max (or VO2 peak) from data
measured during submaximal exercise tests.
We did not evidence signiﬁcant difference between the 6-
MWT HR and the ﬁrst VT-HR in GES and GMI, and found a
signiﬁcant correlation between these parameters. However, our
complementary analysis suggest that it remains questionable to
consider that these two HR can be considered as interchangeable
for training purpose, especially in the GES (mean bias ( 95%
IC) = 0.2  15.9 bpm). The correlation between the 6-MWT HR and
the ﬁrst VT HR was the highest in the GMI (r = 0.78, P < 0.05), with a
small mean bias (2.1 bpm), but a standard deviation representing
twice this mean bias ( 4.3 bpm). This probably explains why the
95% CI remains quite high as the difference might rise up to 12 bpm.
However, this appears much more acceptable in clinical practice
than that evidenced in GES and GMI (> 30%). Moreover, the clinical
implications might be negligible as the magnitude of the bias in
GMI group appears limited with a small effect size (Hedges
g = 0.3  0.41).
In CR, training intensity is usually prescribed using a THR
deriving from max HR observed at the end of baseline CPET.
However, the recommended intensity is not precisely deﬁned [1,2],
and choosing THR as a fraction of max HR probably leads to bias in
estimating the optimal training intensity. Indeed, the relationship
between exercise relative intensity and HR is disturbed by
medications, especially beta-blocker therapy [38], or by the heart
disease itself. Moreover, the nature of the initial CPET with
workload increments is very different from exercise training
sessions usually performed in CR. In athletes, ﬁeld tests are widely
used to build training strategy, as laboratory testing is hard to
perform for all athletes. Since the famous 12-min running test
described by Cooper [39], large numbers of similar tests have been
developed and studied, especially in endurance sports. Few of
them have been extensively studied and validated, even though
they are widely used to plan training sessions [40].
In this context, with regards to our results in the GMI, the 6-
MWT HR could be considered as a valuable alternative in training
intensity prescription and assessment of improvement of sub-
maximal aerobic capacity, especially in CAD patients. Indeed, given
its self-paced nature, one can consider that it leads patient to
spontaneously adopt the most efﬁcient walking speed from a
bioenergetics point of view, that could help in improve patients
adherence to exercise training as we previously reported [18]. This
may warrant the possibility of sustaining such efforts long enough
to induce signiﬁcant improvements in exercise capacity.
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results with caution. First, the number of patients was quite
limited, especially in the GMI. This probably limits the statistical
power of our results. We also included selected patients (stable
patients, with an intermediate risk proﬁle, without ischemia and
other co-morbidities), without women in the GMI group. Second,
the assumption made on the intensity of exercise as a fraction of
maximal HR could be a source of bias due to the different nature of
the exercises. Despite the well-known differences between walk
tests and ergocycle incremental tests with regard to the amount of
exercising muscle mass and ergonomics [41], we used the
ergocycle since it has been recommended as a standard for the
assessment of exercise tolerance in healthy subjects [42]. However,
to date, most of the studies exploring the relative intensity of the
6-MWT in patients with cardiorespiratory diseases have also
performed their symptom-limited exercise test on ergocycle
[15,32,43].
Finally, in the GES, the subjects were volunteers recruited by
information documents posted in associations for the elderly, and
were thus probably more healthy and motivated than old people
who do not take part in such activities. However, observed walking
speeds were quite close to reference values for this age group [44].
In conclusion, the results of this pilot study show that 6-MWT-
HR and VT-HR do not appear interchangeable at the individual
level in healthy elderlies and CHF patients. In CAD patients, further
studies on a larger sample could help in conﬁrming or inﬁrming,
the clinically negligible difference between those parameters in
stable CAD patients under optimal medical treatment. In case of
negative results, the development of other walk tests could help in
conﬁrming the interest of a training prescription based on walking
performance, after an exhaustive study of their cardio-metabolic
requirements.
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